Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 033179/0568 | |
| Pages: | 5 |
| | Recorded: | 06/10/2014 | | |
| Attorney Dkt #: | P-131 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/27/2006
|
Application #:
|
10888849
|
Filing Dt:
|
07/09/2004
|
|
Publication #:
|
|
Pub Dt:
|
02/03/2005
| | | | |
|
Title:
|
CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/09/2007
|
Application #:
|
11405331
|
Filing Dt:
|
04/17/2006
|
|
Publication #:
|
|
Pub Dt:
|
08/24/2006
| | | | |
|
Title:
|
CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
|
|
|
Assignee
|
|
|
|
|
| 901 GATEWAY BOULEVARD |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
Correspondence name and address
|
| |
JEFFREY A. HAGENAH
|
| |
PATENT DEPARTMENT
|
| |
THERAVANCE BIOPHARMA US, INC.
|
| |
901 GATEWAY BOULEVARD
|
| |
SOUTH SAN FRANCISCO, CALIFORNIA 94080
|
Search Results as of:
05/30/2024 12:38 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
